Table 1.
Baseline characteristics of trial participants
| Baseline characteristic | Amoxicillin | Placebo |
|---|---|---|
| Women | 624/1038 (60.1%) | 600/1023 (58.7%) |
| Age (years) | 48.6 (16.7) | 49.3 (16.4) |
| Non-smoker (past or present) | 477/1037 (46.0%) | 483/1022 (47.3%) |
| Illness duration before index consultation (days) | 9.5 (8.0) | 9.3 (7.2) |
| Respiratory rate (breaths per minute) | 16.9 (3.3) | 16.9 (3.3) |
| Body temperature (°C) | 36.7 (3.3) | 36.8 (3.3) |
| Lung disease* | 163/1037 (15.7%) | 147/1023 (14.4%) |
| Mean severity score (all symptoms)† | 2.1 (0.5) | 2.1 (0.5) |
| Mean severity score (cough)† | 3.1 (0.7) | 3.2 (0.7) |
| Sputum production | 814/1036 (78.6%) | 824/1021 (80.7%) |
| Discoloured sputum‡ | 481/968 (49.7%) | 468/957 (48.9%) |
Data are n/N (%) or mean (SD).
*Chronic obstructive pulmonary disease or asthma.
†Severity of symptoms: 1=no problem; 2=mild problem; 3=moderate problem; 4=severe problem.
‡Green, yellow or blood stained.